Evaluation of a Potential Interaction Between New Regimens to Treat Hepatitis C and Warfarin

Drug Interactions with the Direct-Acting Antiviral Combination of Ombitasvir and Paritaprevir-Ritonavir

(2015) Prajakta S. Badri et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Dosing Recommendations for Concomitant Medications During 3D Anti-HCV Therapy

(2015) Prajakta S. Badri et al.   CLINICAL PHARMACOKINETICS

Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor Sofosbuvir

(2015) Brian J. Kirby et al.   CLINICAL PHARMACOKINETICS

New hepatitis C virus therapies

(2015) Paul Y. Kwo et al.   Current Opinion in Organ Transplantation

Ledipasvir/Sofosbuvir: A Review of Its Use in Chronic Hepatitis C

(2015) Gillian M. Keating   DRUGS

Prevalence and Treatment of Chronic Hepatitis C Virus Infection in the US Department of Veterans Affairs

(2015) L. A. Beste et al.   EPIDEMIOLOGIC REVIEWS

Drug interactions with new hepatitis C oral drugs

(2015) Vincent Soriano et al.   Expert Opinion on Drug Metabolism & Toxicology

Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvir

(2015) Rajeev M. Menon et al.   JOURNAL OF HEPATOLOGY

Ritonavir-boosted protease inhibitor based therapy: a new strategy in chronic hepatitis C therapy

(2015) Samuel W Brayer et al.   Expert Review of Gastroenterology & Hepatology

Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation Statement

(2013) Virginia A. Moyer   ANNALS OF INTERNAL MEDICINE

A randomised study of the effect of danoprevir/ritonavir or ritonavir on substrates of cytochrome P450 (CYP) 3A and 2C9 in chronic hepatitis C patients using a drug cocktail

(2013) Peter N. Morcos et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Warfarin Therapy in the HIV Medical Home Model: Low Rates of Therapeutic Anticoagulation Despite Adherence and Differences in Dosing Based on Specific Antiretrovirals

(2012) Albert M. Anderson et al.   AIDS PATIENT CARE AND STDS

Oral Anticoagulant Therapy

(2012) Walter Ageno et al.   CHEST

Noninvasive assessment of liver fibrosis

(2010) Stella M. Martínez et al.   HEPATOLOGY

Induction Effects of Ritonavir: Implications for Drug Interactions

(2008) Michelle M Foisy et al.   ANNALS OF PHARMACOTHERAPY

Drug Interactions between Warfarin and Efavirenz or Lopinavir-Ritonavir in Clinical Treatment

(2007) S. Bonora et al.   CLINICAL INFECTIOUS DISEASES